FC gamma RIIa and FC gamma RIIa polymorphisms (SNPs) and cetuximab (C) benefit in the EXPERT-C trial.

F. Sclafani, D. Gonzalez de Castro, D. Cunningham, S.H. Wilson, C. Peckitt, J. Capdevila, B. Glimelius, S.R. Keranen, R. Begum, G. Brown, D.M. Tait, A. Wotherspoon, J. Thomas, J.R. Oates, L. Chau

Research output: Contribution to conferenceOtherpeer-review

Cite this